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Capnocytophaga ochracea (Bacteroides ochraceus) is a gram-negative, nonsporeforming capnophilic rod that produces yellow-orange pigmentation and is a part of the normal oral flora in healthy individuals (5) . Recently, Forlenza et al. (1) described this organism as a cause of bacteremia in immunocompromised hosts. In this report, we describe the presence of C. ochracea septicemia in a patient with acute myelogenous leukemia.
CASE REPORT
A 21-year-old black male was referred to our hospital with a history of anemia, fever of unknown etiology, and lymphadenopathy characterized On this day it was also noted that the patient's oral hygiene, which had been poor at admission, had deteriorated, and his gums were bleeding. A rectal abscess cultured on day 75 contained a mixture of aerobic, facultative, and anaerobic organisms (E. coli, diphtheroids, Streptococcus faecalis, Eubacterium lentum, and Peptococcus sp.) and was considered to be a possible source of the patient's fever. These culture results led to the addition of chloramphenicol to the patient's antibiotic treatment regimen on day 80. On day 85, the laboratory reported the recovery of an unusual yellow-orange, gram-negative rod which was only detected by seventh-day "blind" subculture of the blood cultures collected on day 77.
The patient became afebrile on hospital day 90, and all antibiotics were discontinued 2 days later. The patient was discharged on hospital day 100. The two blood cultures taken on day 77 grew a gram-negative rod identified in our laboratory as C. ochracea (B. ochraceus).
MATERIALS AND METHODS
Blood specimens were collected and subcultured by methods previously described (4) . Each blood specimen was thoroughly mixed and divided equally among four 50-ml blood culture bottles. Two of these contained 50 ml of Columbia broth modified by the addition of L-cysteine to a final concentration of 0.05%. The remaining two bottles also contained the modified medium supplemented with sucrose to a final concentration of 10%. One isotonic and one hypertonic bottle were vented after addition of the blood specimen. Ail four culture bottles were incubated at 35°C for a period of 7 days.
Biochemical tests employed to characterize our strain of C. ochracea were those offered by the Minitek system (BBL Microbiology Systems, Cockeysville, Md.) using the anaerobe inoculation broth. Minitek tests were inoculated in accordance with the manufacturer's recommendation and were incubated at 370C in a glove box (Coy Manufacturing, Ann Arbor, Mich.) with an atmosphere of 85% N2, 10% C02, and 5% H2.
Gas chromatographic analysis of fermentation products produced by the organism in peptone-yeast-glucose broth after 48 h of anaerobic incubation were conducted by methods previously described (2 Leadbetter and co-workers (3) proposed that the genus and species designation C. ochracea be used in place of B. ochraceus because the organism requires increased carbon dioxide tension for growth (capnophilic) and exhibits gliding motility as do members of the genus Cytophaga. Thus the genus designation Capnocytophaga describes the unique characteristics of the organism which are not shared by members of the genus Bacteroides.
The new genus is distinct from other genera of gliding bacteria (Cytophaga and Flexibacter) in that Capnocytophaga is catalase and oxidase negative, strictly fermentative, requires carbon dioxide, and fails to produce lactic, propionic, and butyric acids as products of fermentation (3, 8) . Three species of the new genus have been proposed: C. ochracea, C. gingivalis, and C. sputigena. Williams and co-workers (11) have recently reported that seven of the eight strains identified as Center for Disease Control group DF-1 (10) exhibited a high degree of deoxyribonucleic acid relatedness with C. ochracea, as did four isolates previously identified as B. ochraceus. Identical conclusions were obtained in a collaborative study of 21 isolates initially characterized as DF-1, B. ochraceus, or Capnocytophaga sp. (6) . This collaborative study, like that of Williams and colleagues, found a high degree of deoxyribonucleic acid relatedness among the organisms studied and concluded that the genus Capnocytophaga was an appropriate designation for the organism.
The spreading colonial morphology observed by us was noted by Leadbetter and co-workers to depend on the medium employed (3). These investigators observed the spreading morphology on sheep blood agar manufactured by BBL, but not on that produced by other manufacturers. We also employed the medium manufactured by BBL. Further investigation by Leadbetter and colleagues revealed that the spreading morphology occurred on media that contained at least 2% agar, but not on media with lower agar content (3).
C. ochracea and other members of the genus are found in the gingival sulci of humans and are also found in periodontal pockets in patients suffering from periodontal disease (5) . The relative quantity and predominance of Capnocyon June 23, 2017 by guest http://jcm.asm.org/ Downloaded from tophaga spp. has been reported to be increased in patients with advanced forms of periodontal disease (5) .
Aside from our report, there are only four other reports which document the recovery of C. ochracea in blood cultures. No clinical history is available for two patients whose blood cultures yielded Capnocytophaga strains included in the taxonomic study of Williams and co-workers (11). Six other clinical isolates cited in the study of Newman and co-workers (6) also lack clinical description of the patients involved. Shurnn and co-workers (7) described the alteration of polymorphonuclear leukocyte function and morphology in two patients with dental disease associated with Capnocytophaga spp. One ofthese patients had multiple myeloma and evidence of destructive dental disease, and C. ochracea was recovered from blood cultures obtained 3 days apart.
Forlenza and colleagues have described six patients who experienced 10 episodes of sepsis caused by Capnocytophaga sp. (1) . Five of the six patients were less than 16 years of age. The five children had either myeloblastic leukemia or acute lymphocytic leukemia, whereas the single adult patient had adenocarcinoma. Each of the patients was granulocytopenic, and 7 of the 10 episodes occurred while the patient was receiving antimicrobial therapy. All patients had ulcerations of their oral mucosa, and 8 of the 10 had bleeding gums. The patient that we describe is similar to the six patients described by Forlenza et al. (1) in that he was severely leukopenic, had bleeding gums, and developed septicemia while he was receiving antimicrobial therapy.
Clinical microbiologists should be aware of Capnocytophaga sp. and its unusual cultural and biochemical characteristics. Its association with septicemia in the leukopenic patient and its role in periodontal disease require further study.
